MoneyWorks4Me

Dr. Lal PathLabs informs about earnings call transcript

15 Nov 2021 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal PathLabs has informed that it attached Financial Results Conference Call Transcript of the Company for Q2 FY22.

The above information is a part of company’s filings submitted to BSE.

Peers